Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million ≈ $10.12 Million USD) by net assets (CN¥2.13 Billion ≈ $311.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Anhui Fengyuan Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Anhui Fengyuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Anhui Fengyuan Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XiAn Dagang Road Machinery Co
SHE:300103
|
-0.003x |
|
Henan Rebecca Hair Products Co Ltd
SHG:600439
|
0.031x |
|
Banyan Gold Corp
V:BYN
|
0.025x |
|
Beijing Kaiwen Education Technology Co Ltd
SHE:002659
|
0.034x |
|
Hangzhou Todaytec Digital Co Ltd Class A
SHE:300743
|
0.060x |
|
Qtone Education Group Guangdong Ltd
SHE:300359
|
-0.005x |
|
Dipula Income Fund Ltd
JSE:DIB
|
0.021x |
|
Foresee Pharmaceuticals Co Ltd
TWO:6576
|
-0.162x |
Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see 000153 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.13 Billion ≈ $311.10 Million |
CN¥119.30 Million ≈ $17.46 Million |
0.056x | -9.06% |
| 2024-12-31 | CN¥2.05 Billion ≈ $299.38 Million |
CN¥126.24 Million ≈ $18.47 Million |
0.062x | -53.53% |
| 2023-12-31 | CN¥1.92 Billion ≈ $280.78 Million |
CN¥254.75 Million ≈ $37.28 Million |
0.133x | -47.05% |
| 2022-12-31 | CN¥1.75 Billion ≈ $256.78 Million |
CN¥439.99 Million ≈ $64.38 Million |
0.251x | +64.19% |
| 2021-12-31 | CN¥1.56 Billion ≈ $227.94 Million |
CN¥237.88 Million ≈ $34.81 Million |
0.153x | -24.47% |
| 2020-12-31 | CN¥1.45 Billion ≈ $211.88 Million |
CN¥292.75 Million ≈ $42.84 Million |
0.202x | +305.23% |
| 2019-12-31 | CN¥1.33 Billion ≈ $194.20 Million |
CN¥66.21 Million ≈ $9.69 Million |
0.050x | -72.41% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.03 Million |
CN¥233.59 Million ≈ $34.18 Million |
0.181x | +321.21% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.59 Million |
CN¥52.40 Million ≈ $7.67 Million |
0.043x | -36.72% |
| 2016-12-31 | CN¥1.15 Billion ≈ $168.69 Million |
CN¥78.21 Million ≈ $11.44 Million |
0.068x | +76.59% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.29 Million |
CN¥45.50 Million ≈ $6.66 Million |
0.038x | +319.25% |
| 2014-12-31 | CN¥1.15 Billion ≈ $167.83 Million |
CN¥10.51 Million ≈ $1.54 Million |
0.009x | +113.74% |
| 2013-12-31 | CN¥1.05 Billion ≈ $154.28 Million |
CN¥-70.31 Million ≈ $-10.29 Million |
-0.067x | -213.22% |
| 2012-12-31 | CN¥775.01 Million ≈ $113.41 Million |
CN¥45.65 Million ≈ $6.68 Million |
0.059x | -18.14% |
| 2011-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥55.06 Million ≈ $8.06 Million |
0.072x | -1.45% |
| 2010-12-31 | CN¥753.81 Million ≈ $110.31 Million |
CN¥55.04 Million ≈ $8.05 Million |
0.073x | +52.92% |
| 2009-12-31 | CN¥678.70 Million ≈ $99.31 Million |
CN¥32.41 Million ≈ $4.74 Million |
0.048x | -37.32% |
| 2008-12-31 | CN¥654.09 Million ≈ $95.71 Million |
CN¥49.82 Million ≈ $7.29 Million |
0.076x | -11.93% |
| 2007-12-31 | CN¥638.89 Million ≈ $93.49 Million |
CN¥55.26 Million ≈ $8.09 Million |
0.086x | +47.97% |
| 2006-12-31 | CN¥620.49 Million ≈ $90.80 Million |
CN¥36.27 Million ≈ $5.31 Million |
0.058x | +0.49% |
| 2005-12-31 | CN¥599.59 Million ≈ $87.74 Million |
CN¥34.88 Million ≈ $5.10 Million |
0.058x | +393.43% |
| 2004-12-31 | CN¥591.07 Million ≈ $86.49 Million |
CN¥-11.72 Million ≈ $-1.71 Million |
-0.020x | +0.35% |
| 2003-12-31 | CN¥576.00 Million ≈ $84.29 Million |
CN¥-11.46 Million ≈ $-1.68 Million |
-0.020x | -206.51% |
| 2002-12-31 | CN¥560.87 Million ≈ $82.07 Million |
CN¥10.48 Million ≈ $1.53 Million |
0.019x | -57.51% |
| 2001-12-31 | CN¥536.15 Million ≈ $78.46 Million |
CN¥23.57 Million ≈ $3.45 Million |
0.044x | -9.55% |
| 2000-12-31 | CN¥532.50 Million ≈ $77.92 Million |
CN¥25.88 Million ≈ $3.79 Million |
0.049x | +154.14% |
| 1999-12-31 | CN¥52.98 Million ≈ $7.75 Million |
CN¥1.01 Million ≈ $148.25K |
0.019x | -- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.